In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells

Molecular Nutrition and Food Research

Volumn 57, Issue 5, 2013, Pages 840-853

  De Amicis, Francesca ^a   Russo, Alessandra ^a   Avena, Paola ^a   Santoro, Marta ^a   Vivacqua, Adele ^a   Bonofiglio, Daniela ^a   Mauro, Loredana ^a   Aquila, Saveria ^a   Tramontano, Donatella ^b   Fuqua, Suzanne Aw ^c   Andò, Sebastiano ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Estrogen receptor; Hsp90; P38MAPK; Progesterone receptor

Indexed keywords

CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; HDAC1 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 90; HISTONE DEACETYLASE 1; NCOR1 PROTEIN, HUMAN; RECEPTOR INTERACTING PROTEIN 140; RNA POLYMERASE II;

ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TEA; TUMOR CELL LINE;

BREAST NEOPLASMS; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE 1; HSP90 HEAT-SHOCK PROTEINS; HUMANS; NUCLEAR RECEPTOR CO-REPRESSOR 1; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA POLYMERASE II; SIGNAL TRANSDUCTION; TEA;

EID: 84876440536     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200560     Document Type: Article

References (53)

1. Herynk, M. H., Fuqua, S. A., Estrogen receptor mutations in human disease. Endocr. Rev. 2004, 25, 869-898.
2. Frech, M. S., Halama, E. D., Tilli, M. T., Singh, B. et al., Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res. 2005, 65, 681-685.
3. Poola, I., Abraham, J., Baldwin, K., Saunders, A. et al. Estrogen receptor h4 and h5 are ligand independent transcription factors and negative modulators of ER-α: cloning from human ovary and functional characterization. Endocrine 2005, 27, 227-238.
4. van Agthoven, T., Timmermans, M., Dorssers, L. C., Henzen-Logmans, S. C., Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer. Int. J. Cancer. 1995, 63, 790-793.
5. Khan, S. A., Rogers, M. A., Obando, J. A., Tamsen, A., Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res. 1994, 54, 993-997.
6. Hong, W. K., Sporn, M. B., Recent advances in chemoprevention of cancer. Science 1997, 278, 1073-1077.
7. De Amicis, F., Giordano, F., Vivacqua, A., Pellegrino, M. et al., Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor {alpha} gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB J. 2011, 25, 3695-3707.
8. Mukhtar, H., Wang, Z. Y., Katiyar, S. K., Agarwal, R., Tea components: antimutagenic and anticarcinogenic effects. Prev. Med. 1992, 21, 351-360.
9. Nakachi, K., Suemasu, K., Suga, K., Takeo, T. et al., Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer. Res. 1998, 89, 254-261.
10. Liao, S., Umekita, Y., Guo, J., Kokontis, J. M. et al., Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 1995, 96, 239-243.
11. Belguise, K., Guo, S., Sonenshein, G. E., Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res. 2007, 67, 5763-5770.
12. Sah, J. F., Balasubramanian, S., Eckert, R. L., Rorke, E. A., Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem. 2004, 279, 12755-12762.
13. Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S. et al., Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 2001, 98, 10350-10355.
14. Liang, Y. C., Lin-shiau, S. Y., Chen, C. F., Lin, J. K., Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell. Biochem. 1997, 67, 55-65.
15. Siddiqui, I. A., Asim, M., Hafeez, B. B., Adhami, V. M. et al., Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J. 2011, 25, 1198-1207.
16. Qanungo, S., Das, M., Haldar, S., Basu, A., Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 2005, 26, 958-967.
17. Tran, P. L., Kim, S. A., Choi, H. S., Yoon, J. H. et al., Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo. BMC Cancer 2010, 10, 276. doi:10.1186/1471-2407-10-276.
18. Carson-Jurica, M. A., Schrader, W. T., O'Malley, B. W., Steroid receptor family: structure and functions. Endocr. Rev. 1990, 11, 201-220.
19. Farabegoli, F., Barbi, C., Lambertini, E., Piva, R., (-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells. Cancer Detect. Prev. 2007, 31, 499-504.
20. De Amicis, F., Zupo, S., Panno, M. L., Malivindi, R. et al., Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter. Mol. Endocrinol. 2009, 23, 454-465.
21. Bunone, G., Briand, P. A., Miksicek, R. J., Picard, D., Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 1996, 15, 2174-2183.
22. Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M. et al., The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J. 1989, 8, 1981-1986.
23. Faivre, E. J., Lange, C. A., Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol. Cell. Biol. 2007, 27, 466-480.
24. Kastner, P., Krust, A., Turcotte, B., Stropp, U. et al., Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 1990, 9, 1603-1614.
25. deGraffenried, L. A., Hilsenbeck, S. G., Fuqua, S. A., Sp1 is essential for estrogen receptor α gene transcription. J. Steroid Biochem. Mol. Biol. 2002, 82, 7-18.
26. Vivacqua, A., Lappano, R., De Marco, P., Sisci, D. et al., G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells. Mol. Endocrinol. 2009, 23, 1815-1826.
27. De Amicis, F., Thirugnansampanthan, J., Cui, Y., Selever, J. et al., Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res. Treat. 2010, 121, 1-11.
28. Guido, C., Panza, S., Santoro, M., Avena, P. et al., Estrogen receptor beta (ER-β) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle 2012, 11, 2911-2921.
29. Hu, X. F., Veroni, M., De Luise, M., Wakeling, A. et al., Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182, 780. Int. J. Cancer 1993, 55, 873-876.
30. Castoria, G., Migliaccio, A., Bilancio, A., Di Domenico, M. et al., PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 2001, 20, 6050-6059.
31. Acconcia, F., Totta, P., Ogawa, S., Cardillo, I. et al., Survival versus apoptotic 17b-estradiol effect: role of ER-α and ER-β activated nongenomic signalling. J. Cell. Physiol. 2005, 203, 193-201.
32. Tillotson, B., Slocum, K., Coco, J., Whitebread, N. et al., Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivo. J. Biol. Chem. 2010, 285, 39835-39843.
33. Hildesheim, J., Salvador, J. M., Hollander, M. C., Fornace, A. J. Jr., Casein kinase 2- and protein kinase A-regulated adenomatous polyposis coli and beta-catenin cellular localization is dependent on p38 MAPK. J. Biol. Chem. 2005, 280, 17221-17226.
34. Duval, D., Malaisé, M., Reinhardt, B., Kedinger, C., Boeuf, H., A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. Cell Death Differ. 2004, 11, 331-341.
35. Jepsen, K., Rosenfeld, M. G., Biological roles and mechanistic actions of co-repressor complexes. J. Cell. Sci. 2006, 115, 689-698.
36. Ogunleye, A. A., Xue, F., Michels, K. B., Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res. Treat. 2010, 119, 477-484.
37. Thangapazham, R. L., Passi, N., Maheshwari, R. K., Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol. Ther. 2007, 6, 1938-1943.
38. De Amicis, F., Santoro, M., Guido, C., Russo, A. et al., Epigallocatechin gallate affects survival and metabolism of human sperm. Mol. Nutr. Food. Res. 2012, 56, 1655-1664.
39. Moiseeva, E. P., Almeida, G. M., Jones, G. D., Manson, M. M., Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol. Cancer Ther. 2007, 6, 3071-3079.
40. Hsieh, T. C., Wu, J. M., Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Int. J. Oncol. 2008, 33, 851-859.
41. Holst, F., Stahl, P. R., Ruiz, C., Hellwinkel, O. et al., Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat. Genet. 2007, 39, 655-660.
42. Schowalter, D. B., Sullivan, W. P., Maihle, N. J., Dobson, A. D. et al., Characterization of progesterone receptor binding to the 90- and 70-kDa heat shock proteins. J. Biol. Chem. 1991, 266, 21165-21173 .
43. Yin, Z., Henry, E. C., Gasiewicz, T. A., Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. Biochemistry 2009, 48, 336-345.
44. Hopp, T. A., Weiss, H. L., Hilsenbeck, S. G., Cui, Y. et al., Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates. Clin. Cancer Res. 2004, 10, 2751-2760.
45. Huang, H. J., Neven, P., Drijkoningen, M., Paridaens, R. et al., Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related. Breast Cancer Res. Treat. 2005, 91, 81-87.
46. Ciocca, D. R., Calderwood, S. K., Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10, 86-103.
47. Basso, A. D., Solit, D. B., Chiosis, G., Giri, B. et al., Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 2002, 277, 39858-39866.
48. Fiskus, W., Ren, Y., Mohapatra, A., Bali, P. et al., Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90. Clin. Cancer Res. 2007, 13, 4882-4890.
49. Bagatell, R., Khan, O., Paine-Murrieta, G., Taylor C. W. et al., Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer. Clin. Cancer Res. 2001, 7, 2076-2084.
50. Lee, M., Kim, E., Kwon, H. J., Kim, Y. M. et al., Radicicol represses the transcriptional function of the estrogen receptor by suppressing the stabilization of the receptor by heat shock protein 90. Mol. Cell. Endocrinol. 2002, 188, 47-54.
51. Khan, J. A., Amazit, L., Bellance, C., Guiochon-Mantel, A. et al., p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization. Mol. Endocrinol. 2011, 25, 1710-1724.
52. Qiu, M., Olsen, A., Faivre, E., Horwitz, K. B. et al., Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Mol. Endocrinol. 2003, 17, 628-642.
53. Arnett-Mansfield, R. L., Graham, J. D., Hanson, A. R., Mote, P. A. et al., Focal subnuclear distribution of progesterone receptor is ligand dependent and associated with transcriptional activity. Mol. Endocrinol. 2007, 21, 14-29.